During the past decade, Florida Retina Consultants conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 9 clinical trials were completed, i.e. on average, 69.2% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 7 clinical trials were completed. i.e. 175% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Florida Retina Consultants" #1 sponsor was "Jaeb Center for Health Research" with 11 trials, followed by "Allergan" with 1 trials sponsored, "Amgen" with 1 trials sponsored, "Bayer" with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Florida Retina Consultants" #1 collaborator was "National Eye Institute (NEI)" with 10 trials as a collaborator, "National Institutes of Health (NIH)" with 6 trials as a collaborator, "Regeneron Pharmaceuticals" with 3 trials as a collaborator, "Juvenile Diabetes Research Foundation" with 2 trials as a collaborator and "Allergan" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Florida Retina Consultants" are "Diabetic Macular Edema" (6 trials), "Diabetic Retinopathy" (6 trials), "Proliferative Diabetic Retinopathy" (2 trials), "Vitreous Hemorrhage" (2 trials) and "Central Retinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Florida Retina Consultants" in a lesser frequency.

Most popular intervention types in "Florida Retina Consultants" are "Drug" (15 trials), "Other" (4 trials), "Procedure" (4 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Deferred aflibercept" (2 trials), "Deferred laser" (2 trials), "Prompt aflibercept" (2 trials) and "Ranibizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Florida Retina Consultants" are 17 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Florida Retina Consultants". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Florida Retina Consultants, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Florida Retina Consultants, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".